| Active Not Recruiting | Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs Gastroenteropancreatic Neuroendocrine Tumors, Pheochromocytoma, Paraganglioma | Phase 2 | 2022-08-31 |
| Completed | Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP- Gastroenteropancreatic Neuroendocrine Tumors | Phase 4 | 2021-01-25 |
| Active Not Recruiting | Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET Gastro-enteropancreatic Neuroendocrine Tumor | Phase 3 | 2020-01-08 |
| Completed | [177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion Uptake Neoplasms | Phase 1 / Phase 2 | 2019-05-24 |
| Active Not Recruiting | Post-Authorization Long-Term Safety Study of LUTATHERA Neuroendocrine Tumors | — | 2018-11-28 |
| Terminated | [68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor Breast Cancer, Prostate Cancer, Colorectal Cancer | Phase 2 | 2018-07-03 |
| Terminated | 177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancer Prostatic Neoplasm | Phase 1 | 2018-05-24 |
| Completed | 68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa) Prostate Cancer Metastatic | Phase 1 / Phase 2 | 2018-05-23 |
| Terminated | 99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis Spondyloarthritis | Phase 2 | 2017-09-18 |
| Terminated | 99mTc-rhAnnexin V-128 Imaging and Cardiotoxicity in Patients With Early Breast Cancer Breast Cancer, Doxorubicin Induced Cardiomyopathy | Phase 2 | 2016-11-02 |
| Terminated | 99mTc-rhAnnexin V-128 Imaging for Carotid Atherosclerosis Carotid Artery Plaque | Phase 2 | 2016-06-23 |
| Terminated | 99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis Rheumatoid Arthritis, Ankylosing Spondylitis | Phase 1 / Phase 2 | 2014-12-11 |
| Completed | 99mTc-rhAnnexin V-128: a First In Man Study in Healthy Volunteers Healthy Adult Volunteers | Phase 1 | 2013-04-01 |
| Completed | A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Pr Carcinoid Tumor of the Small Bowel, Neuroendocrine Tumour | Phase 3 | 2012-09-06 |
| Completed | Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison Coronary Artery Disease | Phase 3 | 2011-02-01 |
| Approved For Marketing | EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx Neuroendocrine Tumors | — | — |
| No Longer Available | 177Lu-PSMA-617 Managed Access Program for mCRPC Patients Metastatic Castration-resistant Prostate Cancer (mCRPC) | — | — |